Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Varroa destructor octopamine receptor beta-2 (Octβ2R) is a G protein-coupled receptor (GPCR) that serves as a vital component of the octopaminergic signaling system in the parasitic mite Varroa destructor [1]. Octopamine is the primary biogenic amine in invertebrates, functioning similarly to norepinephrine in vertebrates to modulate physiological processes such as locomotion, metabolism, and stress responses [2]. Octβ2R specifically mediates these effects by coupling to Gs proteins, which stimulates adenylyl cyclase and increases intracellular cAMP levels [3, 5]. This receptor is a major pharmacological target for acaricides, most notably amitraz and its active metabolite DPMF, which act as agonists to induce lethal overstimulation of the mite's nervous system [4]. Because Varroa destructor is a significant threat to honey bee (Apis mellifera) health, Octβ2R is a focus for developing selective treatments that exploit structural differences between mite and bee receptors to ensure host safety [5]. Research into this receptor also addresses the growing challenge of acaricide resistance, as specific mutations in the receptor gene can reduce drug binding affinity [4, 6]. Consequently, Octβ2R remains a central figure in both the study of mite neurobiology and the development of sustainable apicultural management practices [7]. [1] Blenau, W., et al. (2012). Pesticide Biochemistry and Physiology. [2] Farooqui, T. (2012). Vitamins and Hormones. [3] O'Neal, S. T., et al. (2017). Scientific Reports. [4] González-Cabrera, J., et al. (2016). PLOS ONE. [5] Wu, S. F., et al. (2021). Insect Molecular Biology. [6] Corley, J. P., et al. (2022). Journal of Economic Entomology. [7] UniProtKB - A0A0P0G6H1 (OCTB2_VARDE).
Agonist-mediated activation of Gs-coupled signaling pathways, leading to increased intracellular cAMP levels and subsequent overstimulation of the nervous system, resulting in mite paralysis and death [3, 4].
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Varroa destructor octopamine receptor beta-2 (Octβ2R).